The stock market ended the week higher as investors worked through a wave of strong Big Tech earnings, while also navigating ...

On April 26, 2026, Sun Pharmaceutical Industries confirmed that it would acquire Organon & Co. (NYSE:OGN), a U.S. drugmaker, ...

Sun Pharma will acquire Organon for $11.75 billion. Astellas projects Xtandi sales to decline in fiscal year 2026. | Sun ...

Organon (NYSE: OGN) is a global healthcare company with a mission to deliver impactful medicines and solutions for a ...

The acquisition will position India's largest drug company among the top 10 global players in biosimilars and expand its ...

Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC ("KSF") are investigating the proposed sale of Organon & Co. (NYSE ...

India's Sun Pharmaceutical Industries agreed to acquire Organon for $11.75B at $14 per share, positioning Sun as a top-three ...

Indian generic medicines giant Sun Pharmaceutical Industries is buying the women’s health company Organon in a deal worth $11 ...

MAHA clashes over Bayer’s Roundup case at SCOTUS; The impact of Sun Pharma’s massive deal for Organon; U.K. biotechs might ...

Sun Pharmaceuticals Industries Ltd. will pay $11.75 billion cash to acquire Organon & Co. The transaction is expected to ...

Organon & Co. (NYSE:OGN) is one of the 10 Stocks Racking Up Monster Gains. Organon soared to a new 52-week high on Monday, as ...